Slingshot members are tracking this event:
Gelesis (PTCHF) Enrolls First Patient in Pivotal Trial GLOW Evaluating Gelesis100 in Weight Loss in Overweight and Obese Adults, Including Those with Prediabetes and Type 2 Diabetes
- Source Link:
Slingshot Insights Explained
Apr 26, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords First Patient Enrollment, Pivotal Trial, Glow, Gelesis100, Weight Loss, Overweight, Obese, Adults, Type 2 Diabetes, Prediabetes